We know dealing with a condition such as Alzheimer’s disease can sometimes feel like an uphill battle, both for the patients and…
Articles by Ana de Barros, PhD
Alzheimer’s research is gaining momentum, with 27 Phase 3 and eight Phase 2 clinical trials either in progress or expected over…
Axsome Therapeutics has announced that the first patient was enrolled in the ADVANCE-1 Phase 2/3 trial evaluating the effectiveness and…
AgeneBio has received a $750,000 grant from the Alzheimer’s Drug Discovery Foundation (ADDF) to support the development of…
William Glass, who has seen the devastating toll that Alzheimer’s disease inflicts on families as a caregiver for his…
Araclon Biotech is launching a Phase 2 clinical trial evaluating its active immunotherapy, or vaccine, ABvac40 for Alzheimer’s disease, after receiving…
Anavex Life Sciences  has presented new information at a New York conference on Anavex 2-73, which prevented further decline…
The $100 million IDEAS (Imaging Dementia — Evidence for Amyloid Scanning) Study is working closely with…
A new study found personalized music and memory therapy helped decrease antipsychotic and anti-anxiety medication use, as well as improve dementia…
The National Institutes of Health (NIH) has awarded Pain Therapeutics a $1.7 million research grant to study PTI-125 as…